U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector transforms.
Related Posts
Trump expected to choose Sen. Marco Rubio for secretary of state
Trump could still change his mind, the sources cautioned, noting that the decision wouldn’t be finalized until the president-elect makes a formal announcement.
Comcast’s potential cable networks separation will test the appetite for media reconfiguration
If Comcast moves forward with its idea to spin off NBCUniversal’s cable networks, it could begin a rollup throughout the media industry.
Airlines divert, cancel more Middle East flights after Iran attacks U.S. military base
Airlines diverted flights in the Middle East on Monday after Iran’s armed forces said the country launched a missile strike on a U.S. military base […]